Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
( c ) GSEA analysis of RNA-seq data from Parental and Resistant AKP organoids
In Japan it has been approved specifically as a diagnostic agent (pralmorelin) for growth hormone deficiency testing, which is a different and narrower category than therapeutic approval
A 4mg (4,000mcg) dose = 4,000 / 5,000 x 100 = 80 units
PEG modification increased the stability of protein and peptide drugs, increased the solubility, reduced the immunogenicity, prolonged the residence time in blood, reduced the protease degradation, and reduced the frequency of drug use
Nevertheless, in support of its use, their benefits were observed without the need to purify LOX and BMP1 from the corresponding cell supernatants
US$ 26.66
US$ 25.88
US$ 24.21
US$ 23.73
